by Dr. Joseph Mercola
May 03, 2022
from
Mercola Website
Story at-a-glance
-
According to U.S. Centers for Disease Control and Prevention
data, more than 1 million excess deaths - that is, deaths in
excess of the historical average - have been recorded since the
COVID-19 pandemic began two years ago, and this cannot be
explained by COVID-19. Deaths from heart disease, high blood
pressure, dementia and many other illnesses rose during that
time
-
Across the world, death rates have also risen in tandem with
COVID shot administration, with the most-jabbed areas surpassing
the least-jabbed in terms of excess mortality and COVID-related
deaths
-
According to Walgreens data, during the week of April 19 through
25, 2022, 13% of unvaccinated persons tested positive for COVID.
Of those who received two doses five months or more ago, 23.1%
tested positive, and of those who received a third dose five
months or more ago, the positive rate was 26.3%. So, after the
first booster shot (the third dose), people are at greatest risk
of testing positive for COVID
-
U.K. government data show the all-cause mortality rate is
between 100% and 300% greater among people who got their first
COVID shot 21 days or more ago. The risk for all-cause death is
also significantly elevated among those who got their second
dose at least six months ago, and mildly elevated among those
who got their third dose less than 21 days ago. As of January
2022, all who got one or more doses at least 21 days ago were
dying at significantly elevated rates
-
Other data also show that COVID mortality rates are far higher
in areas with high vaccination rates, and risk-benefit analyses
reveal the jabs do more harm than good in most age groups
According to U.S. Centers for Disease Control and Prevention data,
1
more than 1 million excess deaths - that is, deaths in excess of the
historical average - have been recorded since the COVID-19 pandemic
began two years ago, and this cannot be explained by COVID-19.
Deaths from heart disease, high blood pressure, dementia and many
other illnesses rose during that time. 2
"We've never
seen anything like it," Robert Anderson, CDC's head of mortality
statistics, told The Washington Post in mid-February 2022. 3
According to University of Warwick researchers,
"the scale of excess
non-COVID deaths is large enough for it to be seen as its own
pandemic." 4
A number of explanations have been offered, including
the fact that lockdowns and other COVID restrictions discouraged or
prevented people from seeking care.
But another, less discussed
factor may also be at play.
Across the world, death rates have risen in tandem with COVID shot
administration, with the most-jabbed areas surpassing the
least-jabbed in terms of excess mortality and COVID-related deaths.
This flies in the face of official claims that the shots prevent
severe COVID infection and lower your risk of death, be it from
COVID or all causes. 5
Boosted? You're Now at Highest Risk of COVID
Ever since the announcement that the COVID "vaccines" would be using
novel mRNA gene transfer technology, I and many others have warned
that this appears to be a very bad idea.
Numerous
potential mechanisms for harm have
been identified and detailed in previous articles, and we're now
seeing some of our worst fears come to bear.
"Fully vaccinated"
individuals are both more likely to be infected with SARS-CoV-2 and
more likely to die, whether from COVID or some other cause.
As reported by investigative journalist Jeffrey Jaxen in the April
22, 2022, High Wire video
below, data from Walgreens' COVID-19
tracker 6 reveal that COVID-jabbed individuals are testing positive
for COVID at higher rates than the unjabbed.
What's more,
people who
got their last shot five months or more ago have the highest risk...!
As you can see in the screenshot below, during the week of April 19
through 25, 2022, 13% of unvaccinated tested positive for COVID, with Omicron being the predominant variant. (The data reviewed by Jaxen are from the week of April 10 through 16.)
Of those who received two doses five months or more ago, 23.1%
tested positive.
Of those who received a third dose five months
or more ago, the positive rate was 26.3%.
So, after the first
booster shot (the third dose), people are at greatest risk of
testing positive for COVID.
A deeper dive into the data 7 reveals that two doses appear to have
been protective for a short while, but after five months, it becomes
net harmful.
The group faring worst of all is the 12 to 17 cohort,
where no one with one dose tested positive, but after the second
dose, cases suddenly appear, and get higher still after five months.
After the third dose, positive cases drop a bit, but then shoot up
higher than ever after five months. 8
Deaths by Vaccination Status in the UK
Data sets from the U.K. government reveal an equally disturbing
trend.
The raw data from the Office for National Statistics 9 is
difficult to interpret, so Jaxen had data analysts create a bar
graph to better illustrate what the data actually tell us.
A
screenshot from Jaxen's report is below:
Bars going upward are a good thing, as it indicates the risk for
all-cause mortality based on vaccination status is either normal or
reduced.
Bars that dip below zero percent are indicative of
increased all-cause mortality, based on vaccination status.
As you can see, the all-cause mortality rate is between 100% and
300% greater among people who got their first dose 21 days or more
ago.
The risk for all-cause death is also significantly elevated
among those who got their second dose at least six months ago, and
mildly elevated among those who got their third dose less than 21
days ago.
As of January 2022, all who got one or more doses at least
21 days ago were dying at significantly elevated rates.
More Jabs, More COVID Deaths
Everywhere we look, we find trends showing
the COVID shots are
resulting in higher death rates...
Above is an animated illustration
10
from Our World In Data, first showing the vaccination rates of,
South
America, North America, Europe and Africa,
...from mid-December 2020
through the third week of April 2022, followed by the cumulative
confirmed COVID deaths per million in those countries during that
same timeframe.
Africa has had a consistently low vaccination rate throughout, while
North America, Europe and South America all have had rapidly rising
vaccination rates.
Africa has also had a consistently low COVID
mortality rate, although a slight rise began around September 2021.
Still, it's nowhere near the COVID death rates of North America,
South America and Europe, all of which saw dramatic increases.
Here's another one, 11 also sourced from Our World In Data, first
showing the excess death rate in the U.S. (the cumulative number of
deaths from all causes compared to projections based on previous
years), between January 26, 2020, and January 30, 2022, followed by
an illustration of the tandem rise of vaccine doses administered and
the excess mortality rate.
It clearly shows that as vaccination
rates rose, so did the excess mortality rate:
Risk-Benefit Analysis Condemns the COVID Jabs
At this point, we also have the benefit of more than one
risk-benefit analysis, and all show that,
with very few exceptions,
the COVID jabs do more harm than good...
For example, a risk-benefit
analysis 12 by Stephanie Seneff, Ph.D., and independent researcher
Kathy Dopp, published in mid-February 2022, concluded that,
the COVID
jab is deadlier than COVID-19 itself for anyone under the age of 80...
They looked at publicly available official data from the U.S. and
U.K. for all age groups, and compared all-cause mortality to the
risk of dying from COVID-19.
"All age groups under 50 years old are
at greater risk of fatality after receiving a COVID-19 inoculation
than an unvaccinated person is at risk of a COVID-19 death," Seneff
and Dopp concluded.
And for younger adults and children, there's no
benefit, only risk.
"This analysis is conservative," the authors note, "because it
ignores the fact that inoculation-induced adverse events such as
thrombosis, myocarditis, Bell's palsy, and other vaccine-induced
injuries can lead to shortened life span.
When one takes into consideration the fact that there is
approximately a 90% decrease in risk of COVID-19 death if early
treatment is provided to all symptomatic high-risk persons, one can
only conclude that mandates of COVID-19 inoculations are
ill-advised.
Considering the emergence of antibody-resistant variants like Delta
and Omicron, for most age groups COVID-19 vaccine inoculations
result in higher death rates than COVID-19 does for the
unvaccinated."
The analysis is also conservative in the sense that it only
considers COVID jab fatalities that occur within one month of
injection.
As demonstrated by the U.K. data above, the risk of
all-cause death is nearly 300% greater for those who got a second
dose at least six months ago.
Teens Are at Dramatic Risk of Death From the Jabs
Similarly, an analysis 13 of data in the U.S. Vaccine Adverse Events
Reporting System (VAERS) by researchers Spiro Pantazatos and
Herve
Seligmann suggests that in those under age 18, the shots only
increase the risk of death from COVID, and there's no point at which
the shot can prevent a single COVID death, no matter how many are
vaccinated.
If you're under 18, you're 51 times more likely to die from the
COVID jab than you are to die from COVID if not vaccinated.
If you're under 18, you're a whopping 51 times more likely to die
from the jab than you are to die from COVID if not vaccinated.
In
the 18 to 29 age range, the shot will kill 16 for every person it
saves from dying from COVID, and in the 30 to 39 age range, the
expected number of vaccine fatalities to prevent a single COVID
death is 15.
Only when you get into the 60 and older categories do the risks
between the jab and COVID infection even out.
In the 60 to 69 age
group, the shot will kill one person for every person it saves from
dying of COVID, so it's a tossup as to whether it might be worth it
for any given person.
How Many Are We Willing to Sacrifice?
We also have a risk-benefit analysis by researchers in Germany and
The Netherlands.
The analysis was initially published June 24, 2021,
in the journal Vaccines. 14
The paper caused an uproar among the
editorial board, with some of them resigning in protest. 15
In the
end, the journal simply retracted it - a strategy that appears to
have become norm.
After a thorough re-review, the paper was republished in the August
2021 issue of Science, Public Health Policy and the Law. 16
The
analysis found that,
"very likely for three deaths prevented by
vaccination we will have to accept that about two people die as a
consequence of these vaccinations," the authors wrote in a Letter to
the Editor 17 of Clinical and Translational Discovery.
Defending their work,
they went on to note that: 18
"The database we based our analysis on was a large naturalistic
study of the BioNTech vaccine in Israel.
This was the only study at
the time that allowed for a direct estimation of an absolute risk
reduction (ARR) in mortality.
Admittedly, the ARR estimate was only available for a short
observation period of 4 weeks after the first vaccine dose, a point
raised by critics.
One might have wanted a longer observation period
to bring out the benefit of vaccinations more clearly, and our
estimate of a number needed to vaccinate (NNV) of 16 000 to prevent
one death might have been overly conservative.
The recently published 6-month interim report of the BioNTech-regulatory
clinical trial now covers a period long enough to let us look at
this risk benefit ratio once again.
In Table S4 of this publication,
14 deaths are reported in the placebo group (n = 21 921) and 15 in
the vaccination group (n = 21 926).
Among them, two deaths in the placebo-group were attributed to
COVID-19, and one in the vaccination group was attributed to
COVID-19 pneumonia.
This leads to an ARR = 4.56 × 10-5, and
conversely to an NNV = 1/ARR = 21 916 to prevent one death by
COVID-19. This shows that our original estimate was not so far off
the mark.
The most recent safety report of the German Paul Ehrlich Institute
(PEI) that covers all reported side effects since the vaccination
campaign began (27 December 2020 until 30 November 202119... reports 0.02 deaths per 1000 BioNTech vaccinations or 2 per 100 000
vaccinations.
We had gleaned four mortality cases per 100 000 vaccinations (all
vaccines) from the Dutch pharmacovigilance database LAREB. Using the
data of Thomas et al., a liberal NNV = 20 000, we can calculate that
by 100 000 vaccinations we save five lives.
Using the PEI pharmacovigilance report for the same product, we see
that these 100 000 vaccinations are associated with two deaths,
while using the LAREB database back in June 2021, they were
associated with four deaths across all vaccines and are associated
with two deaths in the most recent reports concerning the BioNTech
vaccine ...
In other words, as we vaccinate 100 000 persons, we
might save five lives but risk two to four deaths."
The risk-benefit ratio may be even worse than that, though, as these
calculations do not take into account the fact that passive
pharmacovigilance data,
"are notorious for underestimating casualties
and side effects",
...the authors note, or the fact that severe side
effects such as myocarditis are affecting young males at a
staggering rate, which can reduce lifespan in the longer term.
We Do Not Have a Functioning Pharmacovigilance System
In an August 2021 editorial, editor-in-chief of Science, Public
Health Policy and the Law, James Lyons-Weiler, Ph.D., wrote: 20
"There are two messages from those who hold appointed offices or
other influential positions in Public Health on long-term vaccine
safety.
The first message is that long-term randomized double-blinded
placebo-controlled clinical trials are not necessary for the
long-term study of vaccine safety because we have 'pharmacovigilance';
i.e. long- term post-market safety surveillance that is supported by
widely accessible, passive vaccine adverse events tracking systems.
The second message is that any use of those very same vaccine
adverse events tracking systems that leads to the inference or
conclusion that vaccines might cause serious adverse events or death
is unsupported by such systems ...
When those seeking support for public health initiatives, such as a
new vaccination program, offer evidence that long-term vaccine
safety studies are well in hand due to the possibility of detecting
adverse events that happened following vaccination, they are either:
-
unaware that the vaccine adverse events tracking systems upon
which they are basing their confidence about society's ability to
detect and track vaccine adverse events are alleged to be unable to
be used to infer causal links between health outcomes and
vaccination exposure, or:
-
participating in a disinformation campaign to end scrutiny over
the absence of properly controlled long-term randomized clinical
trials to assess long- term vaccine safety. Neither of these is
sufficient empirical basis for the knowledge claim of long- term
safety...
There must be room for disagreement in science; otherwise, science
does not exist.
It is sad to bear witness to the fact that science
has degenerated into a war against unwanted and inconvenient
results, conclusions and interpretations via the process of
post-publication retraction for issues other than fraud, grave error
in execution, and plagiarism.
The weaponization of the process of retraction of scientific studies
is well underway, and it induces a bias that could be called
"retraction bias", or, in the case in which a few persons haunt
journals in search of studies that cast doubt on their commercial
products, a 'ghouling bias,' which leads to biased systematic
reviews and warped meta-analyses."
In his editorial, Lyons-Weiler specifically criticized the Vaccine
journal for its retraction of the risk-benefit analysis cited above,
and mocked the editorial board members who quit in protest, noting
that "Rage-quitting is not science."
"The resigning editorial board members' knowledge claim is that no
deaths have occurred due to the vaccination program.
As helpful as
that claim might be to a prescribed narrative, it is not based on
empirical evidence, and it is, therefore, unwarranted," Lyons-Weiler
wrote. 21
"From a Popperian view of science, one can see the fatal flaw in the
editorial board members' knowledge claim:
if, as they insist,
passive vaccine adverse events tracking systems cannot test the
hypothesis of causality, then,
how can editorial board members,
resigning or otherwise, know that the events were NOT caused by the
vaccine?...
It is logical to conclude that since passive vaccine adverse event
tracking systems do not lend themselves well to testing hypotheses
of causality, they do not provide the opportunity to design and
conduct sufficiently critical tests of causality, and therefore a
replacement system is needed... one that is suitable to detect
risk."
While we may indeed need better pharmacovigilance, there's really no
doubt at this point that the COVID jabs are ill-advised for most
people.
I believe that in the years to come, people will look back
at this time and vow to never repeat it.
In the meantime, all we can
do is look at and assess the data we do have, and make decisions
accordingly...
Video
New data shows troubling
trend in vaccinated
The High Wire (HW) with
Del Bigtree
Sources and References
1 U.S.
CDC, Excess Deaths Associated with COVID-19
2 MarketWatch
February 16, 2022
3 The
Washington Post February 15, 2022
4 Studies
in Microeconomics October 19, 2021
5 CDC
MMWR October 29, 2021; 70(43): 1520-1524
6 Walgreens
COVID-19 Index
7, 8 Bad
Cattitude Substack April 15, 2022
9 ONS.gov.uk
Deaths by Vaccination Status
10 Twitter
TexasLindsay April 23, 2022
11 Twitter
TexasLindsay April 25, 2022
12 COVID-19
and All-Cause Mortality Data Analysis by Kathy Dopp and
Stephanie Seneff (PDF)
13 COVID
Vaccination and Age-Stratified All-Cause Mortality Risk
(PDF)
14 Vaccines
2021; 9(7): 693
15 Science,
Public Health Policy and the Law August 2021; 3: 81-86, page
82
16 Science,
Public Health Policy and the Law August 2021; 3: 87-89
17, 18 Clinical
and Translational Discovery February 25, 2022; 2(1): e35
19 Paul-Ehrich
Institute December 23, 2021
20, 21 Science,
Public Health Policy and the Law August 2021; 3: 81-86
|